Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Aster DM Quality Care — Q3 FY26 Earnings Presentation
66 slides from Aster Dm Healthcare's earnings presentation, Feb 5, 2026
Slide 1: Filing cover letter to stock exchanges
February 05, 2026 To To The Secretary, The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd, 1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051. Scrip Code: 540975
Slide 2: Investor Presentation
Investor Presentation February 2025 0
Slide 3: Disclaimer
Disclaimer • This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Company Overview
Company Overview
Slide 5: Aster at a Glance
Aster at a Glance Our Presence/Strength1 16 Cities and 202 5,451 5 States Hospitals Capacity beds 10 302 203 Clinics Labs and PECs Pharmacies3 Operational metrics (9MFY26) Karnataka & Maharashtra 61% 3.1 days INR 51,100 Karnataka Hospital: 4, Beds: 1,234 Occupancy ALOS ARPOB Maharashtra Hospital: 1,
Slide 6: Our Vision and Core Values
Our Vision and Core Values Excellence Respect “Surpassing current benchmarks constantly by continually “Treating people with utmost dignity, valuing challenging its ability and skills their culture contributions and fostering a Our Promise to take the organisation to culture that allows each individ
Slide 7: From Clinic to a Healthcare Powerhouse: A Transformational Journey
From Clinic to a Healthcare Powerhouse: A Transformational Journey to a Thriving Hospital Network Kerala Cluster Andhra Pradesh & Telangana 2025 Aster MIMS Kasargod. Kerala 2024 QCIL Merger Announcement Prim e Hospitals – Am eerpet Completed Segregation of GCC Aster Medcity MIMS Calicut Aster Ramesh
Slide 8: Sustained improvement in our India Business performance
Sustained improvement in our India Business performance over the past few years No. of Capacity Beds ARPOB (in 000s) 5,451 5,128 5,159 4,867 45.0 51.1 4,317 40.1 3,757 3,905 44.2 36.5 3,693 33.5 30.1 27.7 9MFY25 9MFY26 FY20 FY21 FY22 FY23 FY24 FY25 9MFY25 9MFY26 FY20 FY21 FY22 FY23 FY24 FY25 Revenue
Slide 9: Merger of Aster DM & Blackstone backed Quality Care
Merger of Aster DM & Blackstone backed Quality Care
Slide 10: Aster DM and Blackstone-backed Quality Care to merge
Aster DM and Blackstone-backed Quality Care to merge and create one of the top 3 hospital chains in India with 10,625+ beds ▪ The board of directors of Aster DM Healthcare Limited (“Aster” or “Aster DM”) approved the merger of Quality Care India Limited (“Quality Care” or “QCIL”) with Aster in one o
Slide 11: Aster DM & Quality Care - Business snapshot
Aster DM & Quality Care - Business snapshot ASTER DM QUALITY CARE ASTER DM QUALITY CARE ▪ One of the leading integrated healthcare ▪ One of the leading healthcare providers ✓ One of the top 3 hospital chains in India providers in South India operating 201 with 19 hospitals & 7 medical centres by rev
Slide 12: Transaction structure (1/2)
Transaction structure (1/2) 0 As of November 2024 Aster Public Blackstone TPG Others Promoters 58.1% 71.8% 23.9% 4.2% 41.9% Aster DM Healthcare Limited QCIL 10
Slide 13: Transaction structure (2/2)
Transaction structure (2/2) 1 Post Initial Share Acquisition Structure Step 1 Initial Share Acquisition - Aster acquired 5% stake in QCIL & issue equivalent value of Aster shares Aster Public Blackstone Blackstone TPG Others Aster DM ▪ Aster DM purchased 5.0% stake Promoters / TPG 56.0% 68.1% 22.7%
Slide 14: Interse Valuation – Aster's valuation reflects a 45% higher multiple
Interse Valuation – Aster’s valuation reflects a 45% higher multiple relative to QCIL FY24 EV/EBITDA (Adj. Post INDAS1) Interse Shareholding 11.4x multiple difference Aster QCIL (In INR Cr) 36.6x Equity Value 22,794 2 16,983 2 Inter-se Shareholding 57.3% 42.7% 25.2x Shareholding Pattern post merger
Slide 15: Strategic rationale behind the merger
Strategic rationale behind the merger ▪ 1. Scale 4. Diversification Merged entity to be one of the top 3 hospital chains in India and with strong presence across Geographically well diversified platform South and Central India with low overlap in cities of presence 2. Enhanced Metrics 5. Growth Pote
Slide 16: Merged Entity to be one of the top hospital chains in India
Merged Entity to be one of the top 3 hospital chains in India by Bed Capacity & Revenue 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Ranking by Bed Capacity1 Ranking by Hospital Revenue1 ~10,800 10,625 2 11,147 Aster + 8,667 QCIL 8,105 5,915 5,800 2 2 5,451 6,528 5,200
Slide 17: Aster + QCIL: Performance Highlights for the Quarter
Aster + QCIL: Performance Highlights for the Quarter 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Total Patient Volume (mn) Revenue from Operations (INR Cr) Operating EBITDA 2 (INR Cr) Operating EBITDA Margin2 (%) 1.97 1.80 2,366 503 21.3% 2,057 20.1% 414 Q3FY25 Q3FY26
Slide 18: Aster + QCIL: Consistently Delivering Robust Performance
Aster + QCIL: Consistently Delivering Robust Performance 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential YoY Total Patient Volume Growth (%) YoY Revenue Growth (%) YoY Operating EBITDA Growth 3 (%) YoY Operating EBITDA Margin3 (%) 22% 20% 9% 15% 23.0% 8% 17% 20.5% 21.3% 8
Slide 19: Financial Metrics
Combined Proforma Numbers for Q3FY26 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Aster + QCIL = Merged Entity* (Figures for Q3FY26) YoY Growth Revenue (INR Cr) 1,186 1,1811 2,366 15% Operating EBITDA2 (INR Cr) 224 279 503 22% Financial Metrics Op EBITDA Margin2 % 18.9
Slide 20: Operational Metrics
Combined Proforma Numbers for Q3FY26 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Aster + QCIL = Merged Entity* (Figures for Q3FY26) YoY Growth No. of Hospitals (Nos) 201 192 39 City Presence (Nos) 16 14 28 Operational Metrics Beds Capacity3 (Nos) 5,450+ 5,170+ 10,620+
Slide 21: Multiple avenues of synergies poised to accelerate growth
Multiple avenues of synergies poised to accelerate growth and profitability 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Integrated ✓ Broader base of star senior specialists and exchange of learnings Doctor Model ✓ Greater ability to attract and retain medical talent w
Slide 22: Well diversified platform with presence across South and Central India
Well diversified platform with presence across South and Central India 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential One of the top 3 hospital Chains in India with strong presence across South & Central India 1 Aster DM and QCIL have limited QCIL micro-market overlap 5
Slide 23: Well diversified platform with presence across 28 cities
Well diversified platform with presence across 28 cities 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Aster QCIL Merged Entity 81% Top 5 Cities 19% Others 76% Top 5 Cities 24% Others 80% Top 10 Cities 20% Others 15% 19% 24% 25% 20% 30% 13% 6% 7% 3% Revenue1 Mix 7% 3% 1
Slide 24: Favorable mix of scaled and growing hospitals for the merged entity
Favorable mix of scaled and growing hospitals for the merged entity 1 Scale 2 Enhanced Metrics 3 Synergies 4 Diversification 5 Growth Potential Total Addition of 4,080+ beds, bringing the total bed capacity to 14,710+ beds 1,030 14,710 1,877 944 10,625 234 Beyond FY26: 234 beds FY27: 944 beds FY28:
Slide 25: Merger Implementation: Progress Update
Merger Implementation: Progress Update In Nov’24, Company announced: Transaction Merger of Quality Care with the Company (“Merger”) and Announcement Preferential allotment of ~3.6% stake to Blackstone and TPG in the Company in lieu of initial acquisition of 5.0% stake in Quality Care by the Comp
Slide 26: Aster DM Healthcare Performance
Aster DM Healthcare Performance For Quarter ending Dec 31, 2025
Slide 27: Aster Revenue and Profitability Snapshot: Q3FY26
Aster Revenue and Profitability Snapshot: Q3FY26 Performance for the quarter Revenue from Operations1 Operating EBITDA and Margin 1,2 PBT and Margin Normalised PAT and Margin 3 (INR Cr) (Post NCI) 1,186 224 140 81 81 1,050 202 129 19.3% 18.9% 12.3% 11.8% 7.7% 6.8% Margin Q3FY25 Q3FY26 Q3FY25 Q3FY26
Slide 28: De-risked business model across multiple specialties
Consciously built a de-risked business model with healthy presence across multiple specialties Geographical Revenue Mix1 Q3FY26 Specialty-wise Revenue Mix Q3FY26 Andhra & Telangana Child and Adolscent 12% [12%] Health, Women's Health, 5% [6%] Multi Speciality, 6% [6%] 16% [18%] Kerala Nephrology And
Slide 29: Steady growth driven by core hospital performance
Aster DM delivered steady growth driven by strong core hospital performance and improving traction in other units Revenue 3 (Figures for 9MFY26) % of Revenue Operating EBITDA INR 3,352 Cr INR 765 Cr Hospitals and Clinics 94% 11% 22.8% YoY Revenue Growth Margins Labs INR 115 Cr INR 14 Cr Labs 3% 15%
Slide 30: Core hospitals business consistent improvement across operational parameters
The core hospitals business has shown consistent improvement across all operational parameters… No. of Hospitals No. of capacity beds Total patient volumes (In Mn) 3.6 3.3 20 5,451 5,159 2.9 19 5,128 4,867 2.9 19 4,317 2.7 19 3,757 3,905 2.2 2.2 17 3,693 14 14 13 1.5 9MFY25 9MFY26 FY20 FY21 FY22 FY2
Slide 31: Robust financial performance trajectory over the years
…resulting in a robust financial performance trajectory over these years Hospital Revenue Hospital Operating Hospital EBITDA EBITDA and Margin and Margin 1 (In INR Cr) (In INR Cr) 22.3% 22.8% 13% 12% 17% 19% 20% 22% Margin 3,990 3,352 3,519 875 3,020 765 2,851 673 688 2,343 538 1,631 1,647 407 212 2
Slide 32: Aster Maturity Wise Hospital Performance: 9MFY26
Aster Maturity Wise Hospital Performance: 9MFY26 30 Key Performance indicators Revenue4 Operational Beds5 Operating Maturity Hospitals3 Operating (INR in Cr) (Census) EBITDA 4 EBITDA %4 ROCE (INR Cr) Over 7 10 71% 68% ₹595 25.4% 36.2% Years ₹2,342 2,642 15% 16% 25.7% 3-7 Years2 3 ₹508 ₹112 22.0% 622
Slide 33: Clear capital allocation strategy for India Business
Clear capital allocation strategy for India Business going forward 31 Further addition of 2,300+ beds, bringing the total bed capacity to 7,800+ beds. 6,830 7,819 500 7,819 100 130 350 300 454 300 75 159 5,451 FY27 : FY28 : Beyond FY28 : FY26 : 754 beds 650 beds 730 beds 234 beds Aster Aster Aster A
Slide 34: Greenfield Expansion
Greenfield Expansion 32 Aster Yeshwanthpur, Bangaluru Aster Capital, Trivandrum Aster Sarjapur, Bengaluru Aster W&C, Hyderabad Multispecialty | 500 Beds (Phase 1) Multispecialty | 454 Beds (Phase 1) Multispecialty | 430 Beds in two phases Mother and Child Care | 300 Beds Construction start date : Ju
Slide 35: Brownfield Expansion
Brownfield Expansion 33 Aster Medcity Aster CMI Aster Whitefield Aster Ramesh Ongole Multispecialty | Current : 874 Beds Multispecialty | Current : 380 Beds Multispecialty | Current : 150 Beds Multispecialty | Current : 502 Beds Bed Expansion :100 Beds Bed Expansion : 159 Beds Bed Expansion : 350 Be
Slide 36: Awards and Recognition
Awards and Recognition Padmashree Dr. Azad Moopen and Pravasi Bharatiya Samman awardee Ms. Alisha Moopen Founder, Chairman and MD Deputy Managing Director • Honoured with • Received the ‘Lifetime Achievement Award’ ‘Dynamic Entrepreneur of the Year’ award at the by Mount Judi Ventures Entrepreneur I
Slide 37: Awards, Recognition and Rankings
Awards, Recognition and Rankings Aster recognised among India's Top 500 Value Creators Global Hospital Rating – Aster Medcity, Aster CMI AHPI Excellence in Healthcare Aster MIMS Calicut Aster Medcity, Kochi – First hospital in India to receive certification & Excellence in Emergency services accredi
Slide 38: High standards of clinical excellence
High standards of clinical excellence Select Firsts achieved by Aster Accreditations 1st in South Asia mixed 1st in India brain- 1st in Kerala to implant reality-based sensing device 1st in North Kerala the Tecnis Pure See International Institute of Robotic Hysterectomy PERCEPT RC for a 72- EDOF IO
Slide 39: Best-in-class Medical Technology
Best-in-class Medical Technology 31 7 17 10 Cathlabs LINACs MRI Machine Robots Surgical Robot, SSI Mantra 3.0 Ortho Robot, ROSA Recon Philips Excimer Laser O-arm India’s first indigenous surgical robot. Cost effective A robotic surgical system, specifically a stereotaxic Aster CMI becomes the first
Slide 40: Digital Initiatives
Digital Initiatives 38 Strengthening Building Blocks forFootprints Through a Robust Phygital Ecosystem Future Growth Updates Updates The "Aster Health" Radiology Reports App has clocked over and Images are now 3,50,000 downloads Aggregating Hospitals, Labs, Data-Driven Patient Digitizing Relationshi
Slide 41: ESG Milestones
ESG Milestones* 39 *All numbers are based on FY25 ~577 ton ~7,414 KL 97%+ ~8,681 tCO2e INR 3.3 Mn 16,100+ E Waste reduction is achieved in FY25,, i.e. 18% from the Reduction in Water consumption in FY25 i.e.~ Energy Consumption sourced from renewable Reduction in Carbon emission in FY25 through Wort
Slide 42: Aster Financial Summary: Profitability Statement
Aster Financial Summary: Profitability Statement Particulars Q3FY26 Q3FY25 YoY % 9MFY26 9MFY25 YoY % Revenue from Operations 1,186 1,050 13% 3,461 3,138 10% Material Cost2 267 247 786 713 Doctors Cost 270 229 767 691 Employee Cost 221 194 628 577 Other Cost 203 178 578 544 Operating EBITDA 224 202 1
Slide 43: Aster Financial Summary- Balance Sheet
Aster Financial Summary- Balance Sheet Particulars (INR Cr) As at Sep 30, 2025 As at Mar 31, 2025 As at Mar 31, 2024 LIABILITIES Shareholders’ Equity 518 500 500 Minority Interest 239 224 158 Other Reserves 3,555 2,469 2,353 Land Revaluation Reserve 460 460 460 Gross Debt 639 642 669 Lease Liabiliti
Slide 44: Growth Strategy
Our Strategic Priorities Focus Areas Capital Investment A ✓ Investing prudently in both brownfield (expanding existing units) and greenfield projects across clusters and opportunistically exploring inorganic opportunities Operational ✓ Focusing more on niche specialties to drive better ARPOB Efficie
Slide 45: Quality Care Overview and Performance
Quality Care Overview and Performance
Slide 46: Quality Care – Performance Highlights for Q3FY26
Quality Care – Performance Highlights for Q3FY26 Revenue Operating EBITDA 1 Op. EBITDA Margin RoCE3 (Pre-Tax) Financial Q3FY26 : INR 1,181 Cr Q3FY26 : INR 279 Cr Q3FY26 : 23.7% Q3FY26 : 20.5% 17% 32% 265 bps 190 bps Q3FY25 : INR 1,007 Cr Q3FY25 : INR 211 Cr Q3FY25 : 21.0% Q3FY25 : 18.6% Capacity Bed
Slide 47: Quality Care – One of the largest hospital chains with focus on emerging cities
Quality Care – One of the largest hospital chains with focus on emerging cities in India About QCIL Key Stats Scale of Operations2,3 Leading Hospital Troika of brands: CARE Hospitals, KIMSHEALTH and Evercare Network Extensive network of 19 hospitals in 14 cities One of India’s largest hospital
Slide 48: Quality Care – High standards of clinical excellence
Quality Care – High standards of clinical excellence Select firsts achieved by QCIL Infrastructure Accreditation in India to use an in India to perform in Central India to in India to perform 1st indigenous coronary 1st heart surgery on a 1st start 3D laparoscopy 1st womb transplant stent foetus sur
Slide 49: Quality Care – Diversified presence across 14 cities
Quality Care – Diversified presence across 14 cities ✓ Nagpur Raipur 105 beds 379 beds ✓ ✓ Indore Dhaka 222 beds 479 beds 5,174+ Capacity Beds ✓ ✓ Aurangabad Chattogram 338 beds 141 beds Broad and spread-out presence in key regions ✓ offer significant opportunities for brownfield expansion and deepe
Slide 50: Appendix
Appendix
Slide 51: Entities of similar scale with strong operating metrics
Entities of similar scale with strong operating metrics creating a robust merged entity Aster QCIL Merged Entity 5,159 5,142 10,301 4,867 # of Capacity 4,885 9,752 4,317 4,608 beds 8,925 FY23 FY24 FY25 FY23P FY24P FY25P FY23P FY24P FY25P 68% 68% 65% 65% 65% 63% 62% 63% 62% Occupancy % FY23 FY24 FY25
Slide 52: Merged entity with diversified revenue mix and strong margin profile
Merged entity with diversified revenue mix and strong margin profile Aster QCIL4 Merged Entity +12%5 8,105 7,314 +12% +12%5 6,183 4,138 3,967 Revenue 3,699 3,200 3,615 2,983 (INR Cr) FY23 FY24 FY25 FY23P FY24P FY25P FY23P FY24P FY25P Margin 16.0% 16.8% 19.5% 21.3% 21.5% 21.5% 18.7% 19.1% 20.5% +20%5
Slide 53: Financial Metrics
Combined Proforma Numbers for 9MFY26 Aster + QCIL = Merged Entity* (Figures for 9MFY26) YoY Growth 3,461 3,4521 6,913 13% Revenue (INR Cr) Financial Metrics Operating EBITDA2 (INR Cr) 702 794 1,496 20% Op EBITDA Margin % 20.3% 23.0% 21.6% 120 bps ROCE3 (%) 21.0% 20.5% 20.7% 170 bps Net Debt (INR Cr)
Slide 54: Operational
Combined Proforma Numbers for 9MFY26 Aster + QCIL = Merged Entity* (Figures for 9MFY26) YoY Growth No. of Hospitals (Nos) 201 192 39 City Presence (Nos) 16 14 28 Metrics Metrics 10,620+ Financial Beds Capacity3 (Nos) 5,450+ 5,170+ 6% Operational Occupancy (%) 61% 62% 62% ARPP IP (INR) 1,19,648 1,31,
Slide 55: Aster Revenue and Profitability Snapshot: 9MFY26
Aster Revenue and Profitability Snapshot: 9MFY26 Performance for the Nine Months Revenue from Operations1 Operating EBITDA and Margin 1,2 PBT and Margin Normalised PAT and Margin 3 (Post NCI) (INR Cr) 3,461 702 3,138 468 281 613 413 251 19.5% 20.3% 13.2% 13.5% 8.0% 8.1% Margin 9MFY25 9MFY26 9MFY25 9
Slide 56: Kerala Cluster: Hospitals and Bed Capacity
Kerala Cluster: Hospitals and Bed Capacity Revenue Contribution1 55% Planned Expansion 874 695 425 359 Aster Capital Aster Medcity Aster Medcity MIMS Calicut MIMS Kannur MIMS Kottakkal Kochi, Kerala Kozhikode, Kerala Kannur, Kerala Kottakkal, Kerala Trivandrum Kerala 2014, Owned 2013, Owned 2019, Ow
Slide 57: Kerala Cluster: Performance
Kerala Cluster: Performance Financial Metrics Q3FY26 Q3FY25 YoY Revenue (In INR Cr) Revenue (INR Cr) 629 523 20% 1,801 1,609 2,007 2,108 Revenue Ex-Kasargod (INR Cr) 619 523 19% 1,690 1,318 Op. EBITDA (INR Cr) 144 123 18% 935 875 701 Op. EBITDA Ex-Kasargod (INR Cr) 157 123 28% Op. EBITDA Margin 22.9
Slide 58: Karnataka & Maharashtra Cluster: Hospitals and Bed Capacity
Karnataka & Maharashtra Cluster: Hospitals and Bed Capacity Planned Expansion Revenue Contribution1 33% Aster Aster Yeshwanthpur Sarjapur Bengaluru Bengaluru 500 beds 430 beds 502 380 252 Aster Aster CMI Whitefield Bengaluru Bengaluru Aster CMI Aster Whitefield Aster RV Bengaluru, Karnataka Bengalur
Slide 59: Karnataka & Maharashtra Cluster: Performance
Karnataka & Maharashtra Cluster: Performance Revenue (In INR Cr) Financial Metrics Q3FY26 Q3FY25 YoY 1,160 1,054 1408 Revenue (INR Cr) 383 358 7% 1100 817 655 Op. EBITDA (INR Cr) 84 80 5% 442 433 310 Op. EBITDA Margin 21.9% 22.5% -50 bps 9MFY25 9MFY26 FY19 FY20 FY21 FY22 FY23 FY24 FY25 Operating EBI
Slide 60: Andhra & Telangana Cluster: Hospitals and Bed Capacity
Andhra & Telangana Cluster: Hospitals and Bed Capacity 350 Planned Expansion Revenue Contribution1 12% Ramesh Guntur Guntur, AP 2016, Leased 158 150 150 Aster Ramesh Aster W&C Ongole Hyderabad Prime Hospitals – Ameerpet Ramesh Sanghamitra Aster Narayanadri 75 Beds 300 Beds Hyderabad, Telangana Ongol
Slide 61: Andhra & Telangana: Performance
Andhra & Telangana: Performance Revenue (In INR Cr) Financial Metrics Q3FY26 Q3FY25 YoY 473 412 391 357 370 344 13% 303 314 Revenue (INR Cr) 137 121 279 Op. EBITDA (INR Cr) 18 17 7% Op. EBITDA Margin 13.2% 13.9% -70 bps 9MFY25 9MFY26 FY19 FY20 FY21 FY22 FY23 FY24 FY25 Operating EBITDA1 (In INR Cr) H
Slide 62: Quality Care – Performance Highlights for 9MFY26
Quality Care – Performance Highlights for 9MFY26 Revenue Operating EBITDA 1 Op. EBITDA Margin RoCE3 (Pre-Tax) Financial 9MFY26 : INR 3,452 Cr 9MFY26 : INR 794 Cr 9MFY26 : 23.0% 9MFY26 : 20.5% 16% 24% 150 bps 190 bps 9MFY25 : INR 2,973 Cr 9MFY25 : INR 639 Cr 9MFY25 : 21.5% 9MFY25 : 18.6% Capacity Bed
Slide 63: Aster – Board of Directors
Aster – Board of Directors 61 Alisha Moopen T. J. Wilson Shamsudheen Bin Mohideen Mammu Haji Deputy Managing Director Non-Executive Director Non-Executive Director Purana Housdurgamvijaya Chenayappillil John James Mathew Deepti George Dr. Azad Moopen Independent Director Independent Director Indepen
Slide 64: Aster – Leadership Team
Aster – Leadership Team 62 Dr. Azad Moopen Alisha Moopen Founder Chairman and Managing Director Deputy Managing Director Dr .Somashekhar S P T.J. Wilson Ramesh Kumar S Sunil Kumar M R Chairman-Medical Group Head - Governance & Advisory Board & Director Chief Financial Officer Chief Operating Officer
Slide 65: Aster – Current Shareholding pattern and Key shareholders
Aster – Current Shareholding pattern and Key shareholders Marquee domestic and foreign institutional investors are currently invested in Aster Shareholding pattern Current Key Institutional Shareholders 15% 40% 26% 18% Promoters FII DII Others As on 31st Dec 2025 63
Slide 66: Thank You
Thank You Investor Relations: investors@asterdmhealthcare.in
Aster DM Quality Care — Q3 FY26 Earnings Presentation on 6ix